Patents Represented by Attorney Rosemarie R. Wilk-Oresian

Find this attorney in the Justia Lawyer Directory

  • Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Patent number: 6869947
    Abstract: The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: March 22, 2005
    Assignee: Novo Nordisk A/S
    Inventors: Anders Bendtz Kanstrup, Christian Klarner Sams, Jane Marie Lundbeck, Lise Brown Christiansen, Marit Kristiansen